Diagnosis and Staging of Chronic Graft-versus-Host Disease in the Clinical Practice

Biology of Blood and Marrow Transplantation

Volumn 17, Issue 2, 2011, Pages 167-175

  Greinix, Hildegard T ^a   Loddenkemper, Christoph ^b,c   Pavletic, Steven Z ^d   Holler, Ernst ^e   Socié, Gerard ^f   Lawitschka, Anita ^g   Halter, Joerg ^h   Wolff, Daniel ^e  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Charité Campus Benjamin Franklin Medical Center   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d NATIONAL CANCER INSTITUTE   (United States)

^e UNIVERSITY OF REGENSBURG   (Germany)

^f SAINT LOUIS HOSPITAL   (France)

^g ST ANNA CHILDREN S HOSPITAL   (Austria)

^h UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Chronic GVHD; Severity scoring; Staging

Indexed keywords

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CHOLESTASIS; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL PRACTICE; DISEASE SEVERITY; HEALTH CARE SURVEY; HUMAN; LIVER DISEASE; PATHOLOGIST; PHYSICIAN; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

ADULT; CHILD; CHRONIC DISEASE; CONSENSUS; CONSENSUS DEVELOPMENT CONFERENCES AS TOPIC; DISEASE PROGRESSION; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INTERNATIONALITY; LIVER DISEASES; LUNG DISEASES; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 79151478086     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2010.07.017     Document Type: Article

References (35)

1. Lee S.J., Vogelsang G., Flowers M.E. Chronic graft-versus-host disease. Biol Blood Marrow Transplant 2003, 9:215-233.
2. Socie G., Stone J.V., Wingard J.R., et al. Long-term survival and late deaths after allogeneic bone marrow transplantation: Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med 1999, 341:14-21.
3. Baird K., Pavletic S.Z. Chronic graft versus host disease. Curr Opin Hematol 2006, 13:426-435.
4. Shulman H.M., Sullivan K.M., Weiden P.L., et al. Chronic graft vs. host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980, 69:204-217.
5. Filipovich A.H., Weisdorf D., Pavletic S., et al. National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005, 11:945-955.
6. Shulman H.M., Kleiner D., Lee S.J., et al. Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. Pathology working group report. Biol Blood Marrow Transplant 2006, 12:31-47.
7. Pavletic S.Z., Martin P., Lee S.J., et al. Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. Response criteria working group report. Biol Blood Marrow Transplant 2006, 12:252-266.
8. Couriel D., Carpenter P.A., Cutler C., et al. Ancillary therapy and supportive care of chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: V. Ancillary therapy and supportive care working group report. Biol Blood Marrow Transplant 2006, 12:375-396.
9. Jagasia M., Giglia J., Chinratanalab W., et al. Incidence and outcome of chronic graft-versus-host disease using National Institutes of Health Consensus criteria. Biol Blood Marrow Transplant 2007, 13:1207-1215.
10. Arora M., Nagaraj S., Witte J., et al. New classification of chronic GVHD: added clarity from the consensus diagnoses. Bone Marrow Transplant 2009, 43:149-153.
11. Cho B.S., Min C.K., Eom K.S. Feasibility of NIH consensus criteria for chronic graft-versus-host disease. Leukemia 2009, 23:78-84.
12. Vigorito A.C., Campregher P.V., Storer B.E., et al. Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD. Blood 2009, 114:702-708.
13. Pavletic S.Z., Lee S.J., Socie G., Vogelsang G. Chronic graft-versus-host disease: implications of the National Institutes of Health consensus development project on criteria for clinical trials. Bone Marrow Transplant 2006, 38:645-651.
14. Shulman H.M., Sharma P., Amos D., et al. A coded histologic study of hepatic graft-versus-host disease after human bone marrow transplantation. Hepatology 1988, 8:463-470.
15. Strasser S.I., Shulman H.M., Flowers M.E., et al. Chronic graft-vs-host disease of the liver: presentation as an acute hepatitis. Hepatology 2000, 32:1265-1271.
16. Chien J.W., Martin P.J., Flowers M.E., Nichols W.G., Clark J.G. Implications of early airflow decline after myeloablative allogeneic stem cell transplantation. Bone Marrow Transplant 2004, 33:759-764.
17. Gunn M.L., Godwin J.D., Kanne J.P., Flowers M.E., Chien J.W. High-resolution CT findings of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation. J Thorac Imaging 2008, 23:244-250.
18. Wolff D., Herzberg P., Heussner P., et al. Chronic GvHD of the lung significantly impairs quality of life and the activity profile-results of a prospective German multicentre validation trial. Bone Marrow Transplant 2009, 43(Suppl 1):P541.
19. Williams K.M., Chien J.W., Gladwin M.T., Pavletic S.Z. Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation. JAMA 2009, 302:306-314.
20. Marras T.K., Chan C.K., Lipton J.H., et al. Long-term pulmonary function abnormalities and survival after allogeneic marrow transplantation. Bone Marrow Transplant 2004, 33:509-517.
21. Dudek A.Z., Mahaseth H., DeFor T.E., Weisdorf D.J. Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes. Biol Blood Marrow Transplant 2003, 9:657-666.
22. Chien J.W., Duncan S., Williams K.M., Pavletic S.Z. Bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation-an increasingly recognized manifestation of chronic graft-versus-host disease. Biol Blood Marrow Transplant 2010, 16(Suppl 1):S106-S114.
23. Greinix H.T., Pohlreich D., Maalouf J., et al. A single-center pilot validation study of a new chronic GVHD skin scoring system. Biol Blood Marrow Transplant 2007, 13:715-723.
24. Flowers M.E., Apperley J.F., van Besien K., et al. A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease. Blood 2008, 112:2667-2674.
25. Jacobsohn D.A., Rademaker R., Kaup M., Vogelsang G.B. Skin response using NIH consensus criteria vs Hopkins scale in a phase II study for steroid-refractory chronic GVHD. Bone Marrow Transplant 2009, 44:813-819.
26. Elad S., Zeevi I., Or R., Resnick I.B., Dray L., Shapira M.Y. Validation of the National Institutes of Health (NIH) scale for oral chronic graft-versus-host disease (cGVHD). Biol Blood Marrow Transplant 2010, 16:62-69.
27. Treister N.S., Stevenson K., Kim H., Woo S.B., Soiffer R., Cutler C. Oral chronic graft-versus-host disease scoring using the NIH consensus criteria. Biol Blood Marrow Transplant 2010, 16:108-114.
28. Perez-Simon J.A., Encinas C., Silva F., et al. Prognostic factors of chronic graft- versus-host disease following allogeneic peripheral blood stem cell transplantation: The National Institutes of Health scale plus the type of onset can predict survival rates and the duration of immunosuppressive therapy. Biol Blood Marrow Transplant 2008, 14:1163-1171.
29. Shulman H.M., Sale G.E., Lerner K.G., et al. Chronic cutaneous graft-versus-host disease in man. Am J Pathol 1978, 91:545-570.
30. Sullivan K.M., Shulman H.M., Storb R., et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood 1981, 57:267-276.
31. Wingard J.R., Piantadosi S., Vogelsang G.B., et al. Predictors of death from chronic graft-versus-host disease after bone marrow transplantation. Blood 1989, 74:1428-1435.
32. Akpek G., Zahurak M.L., Piantadosi S., et al. Development of a prognostic model for grading chronic graft-versus-host disease. Blood 2001, 97:1219-1226.
33. Akpek G., Lee S.J., Flowers M.E., et al. Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study. Blood 2003, 102:802-809.
34. Arora M., Burns L.J., Davies S.M., et al. Chronic graft-versus-host disease: a prospective cohort study. Biol Blood Marrow Transplant 2003, 9:38-45.
35. Jagasia M.H., Savani B.N., Stricklin G., et al. Classic and overlap chronic graft- versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP). Biol Blood Marrow Transplant 2009, 15:1288-1295.